Nonsteroidal anti-inflammatory drugs (e.g. ibuprofen, naproxen, diclofenac)
medication Under reviewNonsteroidal anti-inflammatory drugs (NSAIDs) are a widely used class of medications that reduce pain, inflammation, and fever. Ibuprofen, naproxen, and diclofenac are among the most common examples, available in both over-the-counter and prescription strengths depending on dose and formulation. They are used for short-term relief of aches, musculoskeletal pain, menstrual cramps, headaches, and other mild to moderate pain, as well as for managing inflammatory conditions. NSAIDs work primarily by inhibiting cyclooxygenase (COX) enzymes, which are responsible for converting arachidonic acid into prostaglandins and related eicosanoids that mediate inflammation, pain signaling, and fever. By decreasing prostaglandin synthesis, these agents lower inflammatory responses, reduce sensitization of pain receptors, and reset the hypothalamic temperature-regulating center. Some NSAIDs preferentially inhibit COX-2, which is more involved in inflammation, while others inhibit both COX-1 and COX-2, which also affects protective prostaglandins in the stomach, kidneys, and platelets. In healthy people, short-term use at standard doses can effectively relieve transient pain and discomfort, improve functional capacity, and reduce fever. However, because prostaglandins have important protective roles in multiple organs, NSAIDs can also cause gastrointestinal, renal, hepatic, and cardiovascular adverse effects, especially at higher doses or with prolonged use. They are best considered as symptom-relief medications rather than long-term health-promoting supplements.
Research summary
Research involving healthy adults shows that ibuprofen, naproxen, and diclofenac are consistently effective for short-term analgesia, anti-inflammatory effects, and antipyresis, with a generally favorable safety profile when used at recommended doses for limited periods. Comparative studies indicate differences in duration of action and risk profiles, but overall efficacy for pain relief and inflammation reduction is robust when these drugs are used appropriately. Large randomized trials and meta-analyses demonstrate that higher doses and long-term use in otherwise healthy populations are associated with increased risks of gastrointestinal bleeding, kidney impairment, and major cardiovascular events such as heart attack and stroke, particularly for diclofenac and high-dose ibuprofen. Naproxen appears to have a somewhat more neutral cardiovascular risk profile at equivalent anti-inflammatory doses, but it can still cause gastrointestinal and renal side effects. The consensus among clinical guidelines is that NSAIDs should be used at the lowest effective dose for the shortest possible duration, especially in healthy individuals without chronic inflammatory disease.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Nonsteroidal anti-inflammatory drugs (e.g. ibuprofen, naproxen, diclofenac) to your stack to report effects
Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial.
Nissen SE, Yeomans ND, Solomon DH, et al.
Coxib and traditional NSAID Trialists’ Collaboration: Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs
Coxib and traditional NSAID Trialists’ Collaboration, Baigent C, Bhala N, Emberson J, et al.
No reports yet
Be the first to report this effect and help the community.
Add Nonsteroidal anti-inflammatory drugs (e.g. ibuprofen, naproxen, diclofenac) to your stack to report effects
Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial.
Nissen SE, Yeomans ND, Solomon DH, et al.
No reports yet
Be the first to report this effect and help the community.
Add Nonsteroidal anti-inflammatory drugs (e.g. ibuprofen, naproxen, diclofenac) to your stack to report effects
Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial.
Nissen SE, Yeomans ND, Solomon DH, et al.
Reported Side Effects
No reports yet
Be the first to report this effect and help the community.
Add Nonsteroidal anti-inflammatory drugs (e.g. ibuprofen, naproxen, diclofenac) to your stack to report effects
Coxib and traditional NSAID Trialists’ Collaboration: Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs
Coxib and traditional NSAID Trialists’ Collaboration, Baigent C, Bhala N, Emberson J, et al.
No reports yet
Be the first to report this effect and help the community.
Add Nonsteroidal anti-inflammatory drugs (e.g. ibuprofen, naproxen, diclofenac) to your stack to report effects
Coxib and traditional NSAID Trialists’ Collaboration: Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs
Coxib and traditional NSAID Trialists’ Collaboration, Baigent C, Bhala N, Emberson J, et al.
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
Chronic or recurring pain in joints from arthritis, overuse, or inflammation
Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial.
Nissen SE, Yeomans ND, Solomon DH, et al.
Coxib and traditional NSAID Trialists’ Collaboration: Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs
Coxib and traditional NSAID Trialists’ Collaboration, Baigent C, Bhala N, Emberson J, et al.
May Worsen
Coronary artery disease or other cardiac conditions
Coxib and traditional NSAID Trialists’ Collaboration: Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs
Coxib and traditional NSAID Trialists’ Collaboration, Baigent C, Bhala N, Emberson J, et al.
Research (2 studies)
Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial.
Nissen SE, Yeomans ND, Solomon DH, et al.
Coxib and traditional NSAID Trialists’ Collaboration: Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs
Coxib and traditional NSAID Trialists’ Collaboration, Baigent C, Bhala N, Emberson J, et al.
Community updates
No updates yet for this supplement.
Be the first to share your experience!